Development of Rhyzopertha dominica (F.) (Coleoptera Bostrichidae) on durum wheat kernels and semolina

he time necessary to larvae of Rhyzopertha dominica to drill kernels with or without dusts (semolina or debris from adults), and the possibility of development on semolina were evaluated. T ests were carried out on durum wheat kernels (Triticum durum Desfontaines), debris deriving from rearing, and semolina. Development was observed also on 0.5 and 6 mm of semolina and of debris. T hirty replicates were carried out for each test. The number of first instar larvae, that successfully drill sound kernels within 10 days, was higher by adding semolina or debris. When only kernels were provided, the time needed to larvae to drill increased. Development and the number of emerging adults were not significantly influenced by the addition of semolina to the kernels. Larvae couldn’t develop on 0.5 mm, while an equal number of individuals completed the development to adult in 6 mm of semolina as in the tests with kernels. When development was on debris, a lower number of emerged adults was observed

HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with fanconi anemia

Abstract We report the outcome of 12 consecutive pediatric patients with Fanconi anemia (FA) who had neither an HLA-identical sibling nor an HLA-matched unrelated donor and who were given T cell–depleted, CD34 + positively selected cells from a haploidentical related donor after a reduced-intensity, fludarabine-based conditioning regimen. Engraftment was achieved in 9 of 12 patients (75%), and the cumulative incidence of graft rejection was 17% (95% confidence interval [CI], 5% to 59%). Cumulative incidences of grades II to IV acute and chronic graft-versus-host disease were 17% (95% CI, 5% to 59%) and 35% (95% CI, 14% to 89%), respectively. The conditioning regimen was well tolerated, with no fatal regimen-related toxicity and 3 cases of grade III regimen-related toxicity. The cumulative incidence of transplant-related mortality was 17% (95% CI, 5% to 59%). The 5-year overall survival, event-free survival, and disease-free survival were 83% (95% CI, 62% to 100%), 67% (95% CI, 40% to 93%), and 83% (95% CI, 62% to 100%), respectively. These data demonstrate that a fludarabine-based conditioning regimen, followed by infusion of high doses of T cell–depleted stem cells, is able to ensure engraftment with good overall survival and disease-free survival, confirming the feasibility of haploidentical hematopoietic stem cell transplantation in FA. To the best of our knowledge, this is the largest series of hematopoietic stem cell transplantation from a haploidentical related donor in FA patients reported to date

Are Dried and Powdered Moringa oleifera Lam. Leaves Susceptible to Moths That Feed on Stored Products?

The leaves of Moringa oleifera are increasingly used as a food supplement in several countries due to their nutritional composition, which is rich in protein, vitamins, and mineral salts. Foodstuffs can be damaged by several pests when stored in environments with temperatures that are favorable to insect development; therefore, the susceptibility of M. oleifera leaves to attacks of moths that feed on stored products was tested. Tests were carried out on Pyralid Cadra cautella, Corcyra cephalonica, and Plodia interpunctella, as well as Geometrid Idaea inquinata, which were reared on dried whole or powdered M. oleifera leaves, an artificial diet, or an artificial diet supplemented with dried or powdered leaves. The numbers of adults and the development periods with the different diets were recorded. M. oleifera leaves were unsuitable as a rearing medium for all of the species except I. inquinata, although only a few individuals of this species reached the adult stage. The use of an artificial diet of which one-quarter consisted of dried and powdered leaves did not affect the number of progeny or on the biological cycle, showing that the effect was due to the nutritional composition, as well as to the toxic effect. The storage of M. oleifera as powdered leaves is recommended in order to preserve the nutritional characteristics and avoid damage caused by moth larvae

Evidence for a conserved microbiota across the different developmental stages of Plodia interpunctella

Diversity and composition of lepidopteran microbiotas are poorly investigated, especially across the different developmental stages. To improve this knowledge, we characterize the microbiota among different developmental stages of the Indian meal moth, Plodia interpunctella, which is considered one of the major pest of commodities worldwide. Using culture-independent approach based on Illumina 16S rRNA gene sequencing we characterized the microbiota of four developmental stages: eggs, first-, and last-instar larvae, and adult. A total of 1022 bacterial OTUs were obtained, showing a quite diversified microbiota associated to all the analyzed stages. The microbiotas associated with P. interpunctella resulted almost constant throughout the developmental stages, with approximately 77% of bacterial OTUs belonging to the phylum of Proteobacteria. The dominant bacterial genus is represented by Burkholderia (∼64%), followed by Propionibacterium, Delftia, Pseudomonas, and Stenotrophomonas. A core bacterial community, composed of 139 OTUs, was detected in all the developmental stages, among which 112 OTUs were assigned to the genus Burkholderia. A phylogenetic reconstruction, based on the 16S rRNA, revealed that our Burkholderia OTUs clustered with Burkholderia cepacia complex, in the same group of those isolated from the hemipterans Gossyparia spuria and Acanthococcus aceris. The functional profiling, predicted on the base of the bacterial 16S rRNA, indicates differences in the metabolic pathways related to metabolism of amino acids between preimaginal and adult stages. We can hypothesize that bacteria may support the insect host during preimaginal stages

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

Background Although rabbit anti-T-lymphocyte globulin (ATLG) is largely used for the prevention of immunemediated complications in patients given allogeneic haemopoietic stem-cell transplantation (HSCT) from an unrelated donor, the optimum dose of this drug in children is still undefined. We aimed to test whether a higher dose of ATLG was superior to a lower dose for prevention of grade II–IV acute graft-versus-host disease (GVHD). Methods We conducted a multicentre, randomised, open-label, phase 3 trial in seven Italian centres comparing two different doses of ATLG (30 mg/kg vs 15 mg/kg, given intravenously over 3 days, from day –4 to –2) in children (aged 0–18 years) with haematological malignancies transplanted from an unrelated donor, selected using high-resolution typing for HLA-class I/II loci. All patients received a myeloablative regimen and cyclosporine-A plus short-term methotrexate as post-transplantation GVHD prophylaxis. Patients were randomly assigned (1:1) to either of the two groups and were stratified by the degree of HLA-compatibility with their donor, the source of haemopoietic stem cells used (bone marrow vs peripheral blood stem cells), and the disease risk category. The randomisation was open label; all investigators were aware of the treatment allocation. The primary endpoint of the study was 100-day cumulative incidence of grade II–IV acute GVHD. Statistical analyses were done according to the per-protocol principle. Other outcomes included cumulative incidence of chronic GVHD, non-relapse mortality, disease recurrence, and probability of overall survival and event-free survival. This study was registered with ClinicalTrials.gov, number NCT00934557. Findings Between Jan 15, 2008, and Sept 25, 2012, 89 patients were randomly assigned to the 30 mg/kg ATLG group and 91 to the 15 mg/kg ATLG group; 84 patients in the 30 mg/kg ATLG group and 88 in the 15 mg/kg ATLG group were included in the analysis. The median follow-up for the whole study population was 3·4 years (IQR 1·7–5·1). The 100-day cumulative incidence of grade II–IV acute GVHD was 36% (95% CI 28–48) in the 15 mg/kg ATLG group and 29% (20–40) in the 30 mg/kg ATLG group (hazard ratio [HR] 0·74, 95% CI 0·44–1·25; p=0·26). The cumulative incidence of non-relapse mortality was 9% (5–18) in the 15 mg/kg ATLG group and 19% (12–30) in the 30 mg/kg ATLG group (HR 2·08, 0·89–4·96; p=0·092). Cumulative incidence of disease recurrence was 15% (12–24): 14% (8–23) in the 15 mg/kg ATLG group versus 20% (13–31) in the 30 mg/kg ATLG group (HR 1·54, 0·74–3·21; p=0·25).The 5-year overall survival probability was 70% (62–77) for the whole study population: 78% (69–87) in the 15 mg/kg ATLG group versus 62% (50–73) in the 30 mg/kg ATLG group (HR 1·80, 1·01–3·20; p=0·045). The 5-year event-free survival was 77% for children in the 15 mg/kg ATLG group versus 61% in the 30 mg/kg ATLG group (HR 1·87, 1·07–3·28; p=0·028). Interpretation Children with haematological malignancies transplanted from unrelated donors selected through high-resolution HLA-typing benefit from the use of a 15 mg/kg ATLG dose in comparison with a 30 mg/kg ATLG dose. ATLG at 15 mg/kg should thus be regarded as the standard serotherapy regimen for unrelated donor allogeneic HSCT in this patient population. Future randomised studies will continue to aim to optimise patient outcome and strategies to prevent acute GVHD occurrence